Abstract | AIMS: MATERIAL AND METHODS: One hundred and ten 10-week-old, Sprague-Dawley rats were divided into five groups: group A (20), no treatment. Group B (20), receiving daily both ursodeoxycholic acid (UDCA) 4 mg/kg of body weight and ethanol 1.23 g/kg of body weight added to the drinking water from the beginning of the study through 24 weeks. Group C (30), receiving 18 weekly doses of dimethylhydrazine ( DMH) 21 mg/kg of body weight subcutaneously from the beginning of the study, with the same doses of UDCA and ethanol as in group B. Group D (20), ethylen-diamin-tetracetic acid solution alone for 18 weeks. Group E (20), receiving the same doses of ethanol plus DMH injections as in group C. All experimental animals were sacrificed after 25-27 weeks. RESULTS: No tumors developed in dimethylhydrazine-free groups. No significant differences in number of tumor-free animals, number of tumors per rat, and macro-microscopic tumor findings were seen between animals in group C and animals in group E. CONCLUSIONS:
|
Authors | S Pérez-Holanda, L Rodrigo, J Viñas Salas, C Piñol Felis |
Journal | Revista espanola de enfermedades digestivas
(Rev Esp Enferm Dig)
Vol. 99
Issue 9
Pg. 491-6
(Sep 2007)
ISSN: 1130-0108 [Print] Spain |
Vernacular Title | Efecto del ácido ursodeoxicólico en un modelo experimental de cáncer de colon. |
PMID | 18052642
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cholagogues and Choleretics
- Ursodeoxycholic Acid
|
Topics |
- Animals
- Cholagogues and Choleretics
(therapeutic use)
- Colonic Neoplasms
(prevention & control)
- Disease Models, Animal
- Female
- Male
- Rats
- Rats, Sprague-Dawley
- Ursodeoxycholic Acid
(therapeutic use)
|